Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)
Author(s):
Kavanaugh, A.; McInnes, I.B.; Mease, P.; Krueger, G.G.; Gladman, D.; Heijde, D. van der; Zhou, Y.Y.; Lu, J.D.; Leu, J.H.; Goldstein, N.; Beutler, A.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-09-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 9, p. 1689-1694
